Wyeth (WYE) Inactive 10-K2007 FY Annual report

Filed: 29 Feb 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: addressing, Amen, andLYBRELare, andPROMIL, andVIVIANT, ARAMARK, asEFEXORandEFEXOR, asPREVENARinternationally, bapineuzumab, basic, BioPharma, byPREMPROorPREMARIN, Cavan, centralized, choose, Citicorp, citizen, commodity, coronary, cough, covenant, coveringPROTONIX, decongestant, Deficit, DeLuca, Denise, easier, enantiomer, explicit, external, fair, FDAAA, forALTACE, forENBREL, forPROTONIX, forTYGACILin, forZOSYN, forZOSYNexpired, framework, France, fromALTACE, fromPROTONIX, Geno, Germano, GOLD, Greece, harmonized, heavy, holder, housing, ifPRISTIQ, impaired, impairment, implicate, importantly, includingBENEFIXCoagulation, includingEFFEXORandEFFEXOR, includingPROTONIX, includingTORISEL, includingTYGACIL, infant, insertion, Intelligence, interaction, length, mandatory, medicinal, medicine, milk, NCE, notice, notwithstanding, Nova, ofPREMPRO, ofPREVNAR, ofPROTONIXfollowing, ofRELISTOR, ofVIVIANTfor, ofZOSYNwill, orphan, orPREMARIN, Osmotica, OTC, ourEFFEXORfamily, ourROBITUSSIN, palliative, PE, Peppard, percent, permissive, Pharmacia, pharmacovigilance, phenylephrine, plant, point, Portugal, pose, postmarketing, precisely, presidential, PRISTIQfor, promising, rare, realize, Redmond, refund, regardingPROTONIX, region, retained, satisfaction, Scotia, severalROBITUSSIN, sharp, skin, Spain, statutory, submission, Switzerland, Syndication, tablet, theCENTRUM, theENBREL, Timothy, TNF, toEFFEXORXR, toLYBREL, TORISEL, TORISELandBENEFIX, tumor, turmoil, TYGACIL, UBS, unclear, uncommon, unexpired, universal, vacated, variability, waived, Web, withdrew, withTYGACIL, Zealand

Removed: Amendatory, cardiovascular, CERCLA, contraceptive, Corcoran, efficiency, ERISA, estradiol, expanding, formal, illegal, Kenneth, Lewin, maintaining, Martin, matter, presently, quantitative, reform, request, Shipley, Stafford, Walter, website, working

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

WYE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.3

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Wyeth (the “Company”) on Form 10-K for the fiscal year ended December 31, 2007, as filed with the Securities and Exchange Commission on February 29, 2008 (the “Report”), I, Gregory Norden, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 29, 2008



By		/s/ Gregory Norden
		Gregory Norden Senior Vice President and Chief Financial Officer